Dr. George Diaz has hope for coronavirus treatments and cures

Providence News Team

Dr. George Diaz speaks with Fox News on the prospects for remdesivir as a potential treatment for the coronavirus, expressing that he is hopeful about the access to remdisivir and the effectiveness of the anti-viral against COVID-19.

Dr. George Diaz has hope for coronavirus treatments and cures

New Providence study finds alcohol use, comorbidities among risk factors for early onset colorectal cancer

Novel AI framework anticipated to unlock tumor secrets, lead to new treatments

Providence reports positive Q3 2025 results

Providence and University of Montana partner in transformative research initiative to advance rural health care

Replicating clinical trial results through AI: Providence and Microsoft see possibilities through revolutionary new tool

New studies reveal environmental toll of commonly used inhalers

Praia Health, Providence and Labcorp collaborate to transform patient engagement and lab order adherence

Humana and Providence launch innovative data exchange collaboration to advance value-based care

Providence-affiliated ISB researcher wins Nobel Prize for groundbreaking immune system discovery

Providence and Compassus finalize second phase of joint venture for home-based care services in California

Providence's Accountable Care Organizations save Medicare $177 million in 2024 with continued value-based care delivery

Providence reports Q2 2025 results

Providence study finds AI clinical assistant reduces provider burnout

Providence’s Cherodeep Goswami appointed to American Board of Surgery leadership post

New Study: Providence whole genome sequencing program shows transformative potential for population health

Providence's Orest Holubec tapped to lead Catholic Health Association Board

Providence announces restructure to strengthen delivery of high-quality, compassionate care

32 Providence hospitals honored for commitment to environmental stewardship

Providence makes significant contributions to community benefit, including high-impact initiatives, in 2024.

Providence reports Q1 2025 results